Annovis Bio (ANVS)
(Delayed Data from NYSE)
$18.01 USD
+4.41 (32.43%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $17.66 -0.35 (-1.94%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -0.87 |
EPS Last Quarter | -1.09 |
Last EPS Surprise | 19.26% |
ABR | 1.40 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.35 |
Next Year | -2.82 |
EPS (TTM) | -4.98 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.87 | -0.70 | -3.35 | -2.82 |
# of Estimates | 2 | 2 | 3 | 1 |
Most Recent Consensus | -0.79 | -0.85 | -1.97 | -2.82 |
High Estimate | -0.79 | -0.55 | -1.97 | -2.82 |
Low Estimate | -0.95 | -0.85 | -4.48 | -2.82 |
Year ago EPS | -1.19 | -1.07 | -4.92 | -3.35 |
Year over Year Growth Est. | 26.89% | 34.58% | 31.91% | 15.92% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 2 | 0 |
Up Last 60 Days | 1 | 1 | 2 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.87 | -0.70 | -3.35 | -2.82 |
7 Days Ago | -0.87 | -0.70 | -3.35 | -2.82 |
30 Days Ago | -0.95 | -0.74 | -3.49 | NA |
60 Days Ago | -1.02 | -0.80 | -3.74 | NA |
90 Days Ago | -1.02 | -0.80 | -3.74 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.87 | -0.85 | -2.79 | -2.82 |
Zacks Consensus Estimate | -0.87 | -0.70 | -3.35 | -2.82 |
Earnings ESP | 0.00% | -21.43% | 16.80% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.09 | -1.63 | -1.07 | -1.19 | NA |
Estimate | -1.35 | -1.10 | -1.14 | -0.85 | NA |
Difference | 0.26 | -0.53 | 0.07 | -0.34 | -0.14 |
Surprise | 19.26% | -48.18% | 6.14% | -40.00% | -15.70% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more